avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ets2
|
ENSMUSG00000022895.8 | E26 avian leukemia oncogene 2, 3' domain |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ets2 | mm10_v2_chr16_+_95702044_95702094 | -0.32 | 5.4e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 2.8 | GO:1905072 | cardiac jelly development(GO:1905072) |
2.2 | 6.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.6 | 9.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.5 | 4.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
1.5 | 8.9 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.4 | 7.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.4 | 23.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.4 | 7.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.4 | 4.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.1 | 4.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
1.1 | 3.2 | GO:0019043 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) establishment of viral latency(GO:0019043) release from viral latency(GO:0019046) |
1.1 | 6.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.0 | 5.9 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.9 | 2.7 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.9 | 1.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.9 | 20.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.8 | 3.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.8 | 3.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
0.8 | 3.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.7 | 2.2 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.7 | 2.7 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.6 | 1.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.6 | 3.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 2.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.6 | 1.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 3.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.5 | 2.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 5.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.5 | 1.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.5 | 0.5 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.5 | 1.4 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.5 | 1.4 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.5 | 1.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.4 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 2.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.4 | 3.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 1.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 2.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 6.8 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.4 | 2.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.9 | GO:1990839 | response to endothelin(GO:1990839) |
0.4 | 1.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.4 | 4.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 25.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.4 | 1.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.4 | 1.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.3 | 4.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 1.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 1.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 4.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.0 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.3 | 2.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 2.3 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.3 | 1.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 1.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 3.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.3 | 2.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.3 | 1.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 2.7 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 4.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 2.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 2.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 0.8 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.3 | 2.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.3 | 1.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 4.8 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 1.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.8 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 0.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.7 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.2 | 4.2 | GO:0033327 | male sex determination(GO:0030238) Leydig cell differentiation(GO:0033327) |
0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 3.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.4 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 2.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 2.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 4.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 1.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.2 | 2.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 3.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 1.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.6 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.2 | 1.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) positive regulation of mitochondrial fusion(GO:0010636) |
0.2 | 2.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.0 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.2 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 1.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 3.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 3.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.2 | 0.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 1.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 2.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 2.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.7 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 1.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.2 | 0.5 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 1.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 5.8 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 2.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 2.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 1.0 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 1.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.0 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 1.1 | GO:0021539 | subthalamus development(GO:0021539) |
0.2 | 1.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 18.9 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 1.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 1.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.0 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.5 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 4.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 4.2 | GO:0030811 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.8 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 1.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 1.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 1.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 6.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 1.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 1.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.5 | GO:1903011 | negative regulation of bone development(GO:1903011) negative regulation of osteoclast development(GO:2001205) |
0.1 | 3.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.6 | GO:0060287 | determination of pancreatic left/right asymmetry(GO:0035469) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 4.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 1.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 1.2 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 1.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 1.5 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 1.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 4.2 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 2.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 1.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 3.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.7 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 1.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 2.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 3.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.1 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.5 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.6 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 1.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.0 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 1.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.8 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.5 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 2.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.1 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.0 | 1.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 2.3 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 2.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.7 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 1.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 5.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.9 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 1.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.9 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 1.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.7 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 1.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.6 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.1 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 1.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 1.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.7 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 1.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 1.4 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 2.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 3.1 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.6 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 2.8 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.5 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.8 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 1.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 1.6 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.3 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
0.0 | 1.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.5 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 1.9 | GO:0030100 | regulation of endocytosis(GO:0030100) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 23.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.2 | 1.2 | GO:0098803 | respiratory chain complex IV(GO:0045277) respiratory chain complex(GO:0098803) |
1.0 | 9.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 0.5 | GO:0019034 | viral replication complex(GO:0019034) |
0.5 | 3.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 4.1 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 2.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 5.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 4.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 1.2 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
0.4 | 1.5 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.4 | 4.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 1.1 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.3 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 1.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 0.9 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 1.9 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 3.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 5.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.2 | 2.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 2.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 3.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.7 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 1.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 6.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 3.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 4.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 3.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 6.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 6.8 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.4 | GO:0016589 | NURF complex(GO:0016589) Set1C/COMPASS complex(GO:0048188) |
0.1 | 4.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 4.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 3.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.9 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 2.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 4.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 1.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 3.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 2.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 4.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 2.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 35.1 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 1.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 1.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 4.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 16.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 3.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 3.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.8 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 2.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 2.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 1.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.6 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 3.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 8.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 5.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 1.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 18.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 2.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 10.9 | GO:0005739 | mitochondrion(GO:0005739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.4 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
1.4 | 7.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.3 | 6.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.2 | 3.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
1.1 | 3.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.1 | 3.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.1 | 4.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
1.0 | 4.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 1.0 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.9 | 3.4 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.8 | 2.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.7 | 5.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 4.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.7 | 2.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 3.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 3.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 4.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.6 | 1.8 | GO:0038052 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.6 | 3.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.6 | 1.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.6 | 2.8 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.6 | 1.7 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.6 | 2.2 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.5 | 1.6 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.5 | 2.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 4.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 2.0 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.5 | 1.4 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.5 | 1.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 1.4 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.5 | 1.4 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.4 | 7.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 2.1 | GO:0008384 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) |
0.4 | 5.0 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 2.8 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.4 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 1.4 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.3 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 1.0 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 2.3 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 3.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.0 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 2.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 1.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 3.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 4.1 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 7.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.3 | 2.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 8.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 3.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 3.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 5.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 0.6 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.2 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 6.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 2.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 2.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 1.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 1.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 4.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 4.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 2.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 1.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.5 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 2.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 2.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 4.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 3.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 2.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 3.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 11.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 2.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 3.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.1 | 3.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 2.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 4.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 1.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 20.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 1.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.8 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 2.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 3.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 7.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 3.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 4.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 1.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 2.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 4.8 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 7.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 3.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 3.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 3.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 3.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 11.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 6.9 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 1.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 2.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 8.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 1.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 6.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 16.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 3.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 6.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 5.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 6.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 13.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 8.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 7.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 4.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 3.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 2.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 3.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 4.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 7.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 5.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 6.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 6.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 4.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 3.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 4.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 3.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 2.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 5.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 3.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 4.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 9.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 3.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 5.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 3.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 1.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 3.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 3.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 2.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |